Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 320 (1), 34-37
- https://doi.org/10.1007/bf00499068
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- DOES O-METHYL-DOPA PLAY A ROLE IN LEVODOPA-INDUCED DYSKINESIAS?Acta Neurologica Scandinavica, 2009
- Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatographyAnalytical Chemistry, 1981
- Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood‐brain interfaceAnnals of Neurology, 1980
- A simple, sensitive method for measuring 3,4-dihydroxyphenylacetic acid and homovanillic acid in rat brain tissue using high-performance liquid chromatography with electrochemical detectionLife Sciences, 1979
- Liquid chromatographic analysis of catecholamines routine assay for regional brain mappingLife Sciences, 1976
- Microassay of human erythrocyte catechol-O-methyltransferase: Removal of inhibitory calcium ion with chelating resinClinica Chimica Acta; International Journal of Clinical Chemistry, 1975
- 3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrierLife Sciences, 1975
- 3-O-methyl metabolites of catecholamines: Automated fluorometric assay and their plasma levels in patients receiving levodopa and carbidopaBiochemical Medicine, 1974
- 3-Methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1972
- 3-O-Methyldopa, a New Precursor of DopamineNature, 1971